Harald Reinhart, Chief Medical Officer at Zai Lab Ltd (ZLAB), sold 14,900 shares at $137.39 ($2.1M) on 2021-09-09, disclosed to the SEC on 2021-09-10.
Open-market sale of $2.1M ZLAB by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $137.39 | 2,731 | $375K | 17.9% |
| 2 | $137.39 | 2,731 | $375K | 17.9% |
| 3 | $138.33 | 900 | $124K | 6.0% |
| 4 | $138.33 | 900 | $124K | 6.0% |
| 5 | $139.27 | 569 | $79K | 3.8% |
| 6 | $139.27 | 569 |
| $79K |
| 3.8% |
| 7 | $140.87 | 800 | $113K | 5.4% |
| 8 | $141.92 | 700 | $99K | 4.7% |
| 9 | $141.92 | 700 | $99K | 4.7% |
| 10 | $143.34 | 1,600 | $229K | 11.0% |
| 11 | $144.35 | 800 | $115K | 5.5% |
| 12 | $146.07 | 1,400 | $204K | 9.8% |
| 13 | $146.61 | 500 | $73K | 3.5% |
| Total | $140.40 avg | 14,900 | $2.1M | 100% |
| Filing → |
| ZLAB | SELL | 2024-04-03 | $29K | — | Filing → |
| ZLAB | SELL | 2024-01-03 | $251K | — | Filing → |
| ZLAB | SELL | 2023-03-07 | $459K | — | Filing → |